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Abstract
The importance of bone morphogenetic protein 2 (BMP2) in the skeleton is well known. BMP2 is expressed in a variety of
tissues during development, growth and healing. In this study we sought to better identify the role of tissue-specific BMP2
during post-natal growth and to determine if BMP2 knockout affects the ability of terminally differentiated cells to create
high quality bone material. We targeted BMP2 knockout to two differentiated cell types known to express BMP2 during
growth and healing, early-stage osteoblasts and their progeny (osterix promoted Cre) and vascular endothelial cells
(vascular-endothelial-cadherin promoted Cre). Our objectives were to assess post-natal bone growth, structure and
strength. We hypothesized that removal of BMP2 from osteogenic and vascular cells (separately) would result in smaller
skeletons with inferior bone material properties. At 12 and 24 weeks of age the osteoblast knockout of BMP2 reduced body
weight by 20%, but the vascular knockout had no effect. Analysis of bone in the tibia revealed reductions in cortical and
cancellous bone size and volume in the osteoblast knockout, but not in the vascular endothelial knockout. Furthermore,
forelimb strength testing revealed a 30% reduction in ultimate force at both 12 and 24 weeks in the osteoblast knockout of
BMP2, but no change in the vascular endothelial knockout. Moreover, mechanical strength testing of femurs from
osteoblast knockout mice demonstrated an increased Young’s modulus (greater than 35%) but decreased post-yield
displacement (greater than 50%) at both 12 and 24 weeks of age. In summary, the osteoblast knockout of BMP2 reduced
bone size and altered mechanical properties at the whole-bone and material levels. Osteoblast-derived BMP2 has an
important role in post-natal skeletal growth, structure and strength, while vascular endothelial-derived BMP2 does not.
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Introduction
Bone morphogenetic protein 2 (BMP2) plays critical roles in the
skeleton. Extensive research has focused on BMP2’s ability to
enable differentiation of precursor cells into osteoblasts and
enhance osteoblast function[1–5]. BMP2 is highly expressed in
osteoblasts [6–8], but little is known about how a deficiency of
BMP2 affects differentiated osteogenic cells [9–11]. Furthermore,
research has indicated that BMP2 is expressed in a variety of non-
osseous tissues during development, growth, and healing
[3,6,12,13]. It is unknown if a lack of BMP2 in these other tissue
types affects post-natal bone growth.
BMP2 null mice are embryonic lethal due to defects in heart
development and mesoderm [14]. Thus, conditional knockout
mice must be used to study the effect of BMP2 deficiency on bone
development and growth [9,10]. Tsuji and colleagues knocked out
BMP2 in all osteo- and chondro-progenitor cells and their lineages
(e.g. chondrocytes, osteoblasts and osteocytes) using the limb
specific promoter Prx1-Cre [10]. Surprisingly, these knockout
mice were similar to wildtype mice at birth. However, as early as
one week postnatally they began to exhibit defects in both cartilage
and bone formation, and as they matured the phenotype
worsened. Knockout mice had thinner, less dense bones that
spontaneously fractured. However, it is unclear if one cell type
(progenitor, chondrocyte, osteoblast, osteocyte) is the major
contributor of BMP2 causing the phenotype or if the phenotype
is a result of knockout from all chondro- and osteo- cells. Also, it is
unknown if the spontaneous fractures were due solely to the
smaller size of the knockout bones or if there was a defect in the
bone material of knockout mice [9,10]. In support of the latter, a
recent report indicates that BMP2 deletion in cells of the osteoblast
lineage results in a brittle bone phenotype [15].
Bone development, growth, remodeling, and healing are
dependent on vascular cells and angiogenesis. For example,
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mineralization of the cartilaginous template follows vascular
invasion [16]. Also, the periosteum, the bilayer membrane
surrounding bones that is responsible for circumferential growth
through life, is well vascularized [17]. Inhibition of angiogenesis or
vasodilation during bone healing decreases the generation of new
bone [18–21]. Interestingly, there is also a strong connection
between BMP2 and vascular cells. As previously mentioned, global
loss of BMP2 results in severe heart development defects [14].
Mice lacking BMP2 expression in osteoblasts and osteocytes have
a reduced vascular network [15]; and recent work from our lab
and others have indicated that BMP2 is expressed in vascular cells
during intramembranous bone healing (stress fracture healing and
distraction osteogenesis) [12,13]. Moreover, there is a wealth of
research linking arterial calcification with increased local BMP2
expression [22,23]. To our knowledge there are no studies that
have investigated the role of vascular-derived BMP2 on the
skeleton.
In this study we sought to better identify the role of tissue-
specific BMP2 during post-natal skeletal growth and to determine
if BMP2 knockout affects the ability of terminally differentiated
cells to create normal quality bone material. We targeted BMP2
knockout to two differentiated cell types known to express BMP2
during growth and healing, early-stage osteoblasts (and their
progeny) and vascular endothelial cells. We then assessed bone
growth, structure and strength. We hypothesized that removal of
BMP2 from osteogenic and vascular cells (separately) results in
smaller skeletons with inferior bone material properties.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the IACUC of Washington University
of St. Louis (Protocol Number: 20110209). All efforts were made
to minimize suffering. Mice were maintained in standard housing
with 12 hr light/dark cycles and food and water ad libitum. All dual
energy X-ray absorptiometry, microCT, and forelimb loading
experiments were performed on live animals under anesthesia
(Ketamine & Xylazine – dual energy X-ray absorptiometry or 1–
3% isofluorane – microCT and forelimb loading). Euthanasia was
carried out by CO2 asphyxiation. Three-point bending and
Raman spectroscopy were performed post mortem on harvested
bones.
Transgenic mice with the Bmp2 gene floxed (obtained through
materials transfer agreement with Harvard University) were
crossed with either osterix-promoted Cre (Osx-Cre, B6.Cg-
Tg(Sp7-tTA,tetO-EGFP/Cre)1Amc/J) [24] or vascular-endothe-
lial-cadherin-promoted Cre (VEC-Cre, B6.Cg-Tg(Cdh5-Cre)7M-
lia/J) [25]. Osx-Cre mice had a targeted deletion of BMP2 in
early-stage osteoblasts, which continues as the cells develop into
mature osteoblasts and osteocytes. VEC-Cre mice had a targeted
deletion of BMP2 in vascular endothelial cells.
Male and female mice with the Bmp2 floxed on one (fl/+,
heterozygous) or two (fl/fl, homozygous) alleles were investigated.
Throughout the paper mice with the genotype Bmp2fl/fl; Osx-Cre+
are referred to as Osx-Cre cKO, while littermate mice with the
genotype Bmp2fl/fl without Cre are referred to as Osx-Cre wildtype
(WT). In addition, mice with the genotype Bmp2 fl/fl; VEC-Cre+
are referred to as VEC-Cre cKO, while littermate mice with the
genotype Bmp2fl/fl without Cre are referred to as VEC-Cre WT.
Verification of Knockout
Tissue specific knockout of BMP2 was confirmed in two ways.
First, the intended cell-specific Cre expression was verified. For the
Osx-Cre a green fluorescent protein (GFP) tag was already
attached to the Cre protein; cells currently producing Cre appear
green. The VEC-Cre was crossed into an mTmG transgenic
mouse (Gt(ROSA)26Sortm4(ACTB-tdTomato,2EGFP)Luo/J) [26]. In an
mTmG mouse all normal, non-Cre expressing cells produce a
red fluorescent protein (RFP) in the cell membrane, whereas cells
that have expressed Cre switch to produce a GFP instead of the
RFP. For both mouse lines, forelimbs (ulna and radius with
surrounding muscle) were harvested (n = 3–6/genotype), fixed in
10% neutral buffered formalin overnight, decalcified in 14%
EDTA, and embedded in OCT media for cryosectioning.
Transverse sections were examined near the ulnar midpoint.
Before imaging, the slides were rinsed in water to remove the
OCT media and coverslipped. They were then imaged with 10x,
20x and 406 objective magnification (IX51, Olympus, Center
Valley, PA) using TRITC and FITC filters.
Second, diminished BMP2 protein expression in the target cells
was verified. For both lines, forelimbs were harvested, fixed in
10% formalin overnight, decalcified in 14% EDTA and embedded
in paraffin. Transverse sections were examined near the middle of
the ulna (n = 3/genotype). Immunostaining was performed using
goat ABC staining system (Santa Cruz, sc-2023, Santa Cruz, CA)
with BMP2 antibody (Santa Cruz, sc-6895, 1:100 dilution
overnight at 4uC) following manufacturers’ instructions. After
hydrating, antigen retrieval was performed using a decloaking
chamber (Biocare Medical, 95uC, 10 min, Concord, CA)
containing sodium citrate buffer (pH 6.0). To visualize protein
DAB was applied for 5 min. Sections were not counterstained.
Imaging was performed at 406 (BX51, Olympus).
Whole Body Measures
To measure growth body weight was recorded. In vivo dual
energy X-ray absorptiometry (DXA, Lunar PIXImus GE) was
used to measure percent fat, bone mineral content (BMC) and
areal bone mineral density (aBMD) for the whole body of the
mouse (excluding the head). Two separate cohorts of Osx-Cre
mice were measured at 12 and 24 weeks of age (n = 4–10/group).
A cohort of VEC-Cre mice were measured at 4, 8, 12, 16, 20, and
24 weeks of age (n = 4–5/group).
MicroCT
In vivo microCT was performed on the left tibia of mice to
determine tibia length, cortical and cancellous bone measures
(VivaCT 40, Scanco Medical, Wayne, PA; X-ray tube potential
70 kV, integration time 100 ms, X-ray intensity 114 mA, isotropic
voxel size 21 um, frame averaging 1, projections 500, medium
resolution scan) in accordance with published guidelines [27]. The
following cortical bone measures were determined for 200 mm at
the tibial midpoint: total volume (TV), bone volume (BV), bone
volume to total volume (BV/TV), and tissue mineral density
(TMD). The following cancellous bone measures were determined
for 600 mm distal to the proximal growth plate: total volume (TV),
bone volume (BV), bone volume to total volume (BV/TV),
volumetric bone mineral density (vBMD), trabecular number
(Tb.N), trabecular connectivity density (Conn.D), structure model
index (SMI), trabecular thickness (Tb.Th), and trabecular separa-
tion (Tb.Sp). Two separate cohorts of Osx-Cre mice were
measured at 12 and 24 weeks of age (n = 6–9/group). A cohort
of VEC-Cre mice was measured at 8, 16, and 24 weeks of age
(n = 4–5/group).
Osteoblast & Vascular Cell BMP2 in Skeletal Growth
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Figure 1. Deletion of BMP2 was evaluated in osteogenic cells (Osx-Cre) and vascular cells (VEC-Cre). (A) First, Cre activation was verified
by examination of cortical bone (ulna) and muscle from transverse cross-sections through the mid-forelimb. In control samples the bone is
Osteoblast & Vascular Cell BMP2 in Skeletal Growth
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Mechanical Testing
To assess whole bone strength, mice forelimbs were loaded to
failure using an established technique [28]. Briefly, mice were
anesthetized and the elbow and wrist were held between two
loading cups such that axial compressive loads create bending of
the curved forelimb bones. The upper cup was displaced at a rate
of 0.5 mm/s to compress the whole limb until complete fracture
(DynaMight 8841, Instron, Norwood, MA). During displacement
loading the force was recorded (LabVIEW, National Instruments,
Austin, TX). Subsequent analysis identified the maximal force
sustained by the whole forelimb. Two separate cohorts of Osx-Cre
mice were loaded to fracture at 12 and 24 weeks old (n = 3–4/
group). A cohort of VEC-Cre mice were loaded to fracture at 24
weeks old (n = 3–4/group). Mice were euthanized immediately
following loading.
To assess both whole-bone strength and estimated material
properties, the right and left femora of Osx-Cre mice were
harvested post mortem and loaded in three-point bending (span
length = 7 mm). Prior to testing, the midshaft of the femur (35
slices, 0.56 mm) was scanned using microCT (mCT40, Scanco
Medical; X-ray tube potential 55 kVp, integration time 200 ms,
X-ray intensity 145 mA, isotropic voxel size 16 um, frame
averaging 1, projections 500, medium resolution scan). Femurs
were loaded to failure at a rate of 0.1 mm/s (DynaMight 8841,
Instron) while force and displacement data were collected
(LabVIEW). Non-normalized properties were gathered from the
force-displacement curve including stiffness, ultimate force, post-
yield displacement, energy at ultimate force, and energy to
fracture. Morphological parameters area and cortical thickness
were calculated directly using the cross sectional microCT images.
In addition, the area moment of inertia about the bending axis and
the distance (c) to the farthest point of the cross section from the
neutral axis were determined and used to calculate material
properties of ultimate stress and Young’s modulus. Two separate
cohorts of Osx-Cre mice were loaded at 12 and 24 weeks (n = 3–
8/group).
Raman Spectroscopy
Eleven bilateral humeri from six 24-week-old mice and 11
unilateral femora from eleven 12-week-old mice were used for
Raman spectroscopic analysis. The 24-week-old humeri were from
a mixed group of male and female mice and intended as a pilot
study (see supplemental data in Tables S1). The 12-week-old
femora were the same bones used for three-point bending tests so
that direct correlations between strength and composition could be
made. The articulating ends of the humeri were removed and the
samples were centrifuged to remove marrow. After three-point-
bending, the uneven fracture surface of the femora specimens were
removed using an Isomet saw (Buehler, Lake Bluff, IL) and then
centrifuged at 12,000 rpm to remove marrow. If organic material
such as blood or bone marrow still was visible, the specimen was
rinsed with PBS. If a specimen was highly fluorescent under the
laser, the specimen was soaked in PBS, dried, and re-analyzed.
Therefore, the Raman spectra obtained and interpreted in this
study showed relatively low fluorescence. Six spectra were
collected for each humerus specimen: two near the inner edge of
the cortex, two in the middle of the cortex, and two near the outer
edge of the cortex. Examination of the spectra from the humeri
indicated that the inner edge of the cortex had higher fluorescence
than the other regions, probably due to the proximity of this
region to the marrow cavity, and there were no substantial
differences between the right and left humeri. Thus, for each
femur specimen only four spectra were collected: two in the middle
of the cortex and two near the outer edge. For each parameter,
medians over all spectra taken on an individual specimen were
obtained and used for the statistical analysis. Four femora spectra
and six humeri spectra were determined to be abnormal and were
not included in the statistical analysis.
completely black. The Osx-Cre mouse has a GFP::Cre fusion protein which demonstrated the current expression of Cre in some osteocytes within the
bone and osteoblasts lining the bone surface (open white arrowheads). The VEC-Cre mouse was crossed with mTmG reporter mouse and
demonstrated Cre activation within muscle and periosteum compartments surrounding the bone (filled white arrowheads). (B) Confirmation of the
BMP2 protein deletion was done using immunohistochemistry. In the control sample BMP2 expression was seen in the muscle (blue filled arrows) and
bone-lining cells (thin black arrows). Using the Osx-Cre BMP2 expression was absent in the bone lining cells, but abundantly expressed throughout
the muscle compartment (blue filled arrows). In contrast, using the VEC-Cre expression of BMP2 was limited to osteoblasts lining the bone surface
(thin black arrows). Images are representative of 3–5 sections from 3–6 animals/group.
doi:10.1371/journal.pone.0096862.g001
Figure 2. Whole body DXA results at 12 and 24 weeks for WT and cKOmale mice. (A) Body weight was significantly reduced in the Osx-Cre
cKO and unchanged for VEC-Cre mice. (B) Percent fat was not significantly reduced in the 12- and 24week old Osx-Cre cKO male mice (although it did
reach significance at 24 weeks when male and female data were pooled (ANOVA)). (C) Osx-Cre cKO male mice showed a significant reduction in BMC
at the 12-week time point, with a non-significant trend at 24 weeks (which was significant when male and female data were pooled (ANOVA)). BMC
was unchanged for VEC-Cre mice at either time point.
doi:10.1371/journal.pone.0096862.g002
Osteoblast & Vascular Cell BMP2 in Skeletal Growth
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Spectra were collected using a HoloLab Series 5000 Raman
microprobe (Kaiser Optical Systems Inc., Ann Arbor, MI). A laser
of 532 nm excitation operated at 10 mW power (delivered to the
sample surface) was focused by an 806objective lens (N.A. = 0.75)
to a beam spot of approximately 1 mm diameter. A 2048-channel
CCD detector monitored signal in the spectral range 100–4000
Dcm21. Each spectrum analyzed represents the average of 32
acquisitions of 4-seconds each.
Grams32R (Galactic Software, Inc., Salem, NH) was used for all
spectral processing. Baseline correction was performed on each
spectrum. Spectral peaks were deconvolved into bands of best fit
using a mixed Gaussian-Lorentzian algorithm. To assess the
relative proportions of collagen and mineral, the 1003
Dcm21 band was used to represent collagen and the 960
Dcm21 band was used to represent mineral [29] The width of
the 960 Dcm21 band indicated the degree of crystalline organi-
zation of the mineral. To assess the degree of carbonate
substitution in the mineral, the area of the 1070 Dcm21 band
(for Type-B carbonate substitution) was used to represent the
proportion of carbonate and the area of the 960 D cm21 band to
represent the apatite mineral [30].
Statistics
Data are presented as a mean 6 standard deviation. DXA and
microCT outcomes were analyzed using two-way ANOVA
(factors: genotype and sex) (StatView v. 5.0, SAS Institute, Cary,
NC). Individual ANOVAs were done for Osx-Cre and VEC-Cre
strains, and for each timepoint. The p-values reported in the body
of the text are based on these ANOVAs. If the main genotype
effect was significant (p,0.05) post-hoc test Fischer’s PLSD testing
was performed. In general, males had larger bones than females,
and the genotype effects were similar between sexes. Furthermore,
heterozygous control mice (fl/+, Cre negative) were similar to
homozygous controls (fl/fl, Cre negative) in both Cre strains.
Outcomes for heterozygous Cre positive mice were either similar
to controls or were intermediate between the homozygous controls
and homozygous knockouts. For conciseness, only data for
homozygous male mice are presented in the main Tables and
Figures for two timepoints (12 and 24 weeks for Osx-Cre; 16 and
24 weeks for VEC-Cre). (See the supplementary data in Tables S1
for all additional groups.) In the case of 3-point bending the right
and left femur data were averaged and unpaired t-tests were
performed on the pooled sets. For Raman spectroscopy differences
between the two genotypes were assessed by two-sample t-tests of
the spectral parameter means using Statistical Analysis System
(SAS, Version 9.3 for Windows; SAS Institute, Cary, NC).
Results
BMP2 Deletion in Osteoblasts and Vascular Cells
BMP2 was successfully knocked down in our cells of interest,
early stage osteoblasts and their progeny (including osteocytes),
and vascular endothelial cells. The Osx- and VEC-Cres were
expressed in the expected target tissues (Figure 1A, GFP signal). As
seen in Figure 1A, the GFP signal of the OSX-Cre does not
appear in all bone lining cells or osteocytes at any one time. This is
because the GFP::Cre fusion protein is under that control of the
Osterix promoter which is transiently expressed. Once the
GFP::Cre protein is no longer created (i.e., Osterix is no longer
being expressed) and all the GFP::Cre protein has been degraded,
a cell will not fluoresce even though the knockout has occurred
and the cell can no longer produce a functional BMP2 protein.
The successful targeting of osteoblasts and osteocytes in post natal
mice by this Osx-Cre has recently been reported [24,31] On the
other hand, in the mTmG;VEC-Cre samples, GFP highlights any
cell that has ever expressed Cre (under control of the VECAD
promoter). The Cre recombination causes a switch in the
production of a membrane protein from RFP to GFP. The GFP
expression is maintained by the constitutive activity of the Rosa
locus and thus is ‘‘on’’ for the remainder of the cell’s life and that
Figure 3. MicroCT was used to assess structural properties of the tibia at 12/16 and 24 weeks. (Osx-Cre data shown at 12 weeks, VEC-Cre
data shown at 16 weeks.) Osx-Cre cKO mice had (A) shorter tibia and (B) reduced cortical bone volume with no change in (C) cancellous BV/TV or (D)
cortical TMD. VEC-Cre mice showed no differences in any parameter. (E) Illustrations of cortical bone geometry show a smaller marrow cavity in the
Osx-Cre cKO mice.
doi:10.1371/journal.pone.0096862.g003
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of any daughter cells. Immunohistochemistry showed BMP2
protein in both the muscle capillaries and bone lining cells of
Bmp2fl/fl control mice (Figure 1B, control). BMP2 was absent in the
bone lining cells of the Osx-Cre cKO mice but, as expected,
remained in the muscle capillaries (Figure 1B). In contrast, BMP2
was absent in the muscle capillaries of VEC-Cre cKO mice but, as
expected, remained in bone lining cells. While osteocyte expres-
sion of BMP2 was absent in all IHC samples, it is assumed that if
successful BMP2 knockout in osteoblasts of the OSX-Cre line has
occurred then it is also knocked out of osteocytes.
Osteoblast Knockout of BMP2 Reduces Bone Size, but
Vascular Knockout does not
Osx-Cre cKO mice had 20% lower body weights at both 12
and 24 weeks age (p= 0.04 and 0.004, respectively) compared to
littermate (Bmp2fl/fl) controls. In contrast, VEC-Cre cKO and
littermate control mice had similar weights at each timepoint
(Figure 2A–12 & 24 week males, Table SA in Tables S1– All
groups). At 12 weeks of age the OSX-Cre cKO mice had similar
percent fat as controls, but by 24 weeks old the knockouts had 6%
lower percent fat (p = 0.03). VEC-Cre mice had similar percent fat
as controls at each time point (Figure 2B–12 & 24 week old males,
Table SA in Tables S1– All groups). DXA measurements of
aBMD and BMC were lower in 12 and 24 week old Osx-Cre cKO
mice versus control (p = 0.020 and 0.005, respectively, at 12 weeks;
p = 0.009 and 0.015, respectively, at 24 weeks). VEC-Cre cKO
had no effect on aBMD or BMC at any time point (Figure 2C–12
& 24 week males, Table SA in Tables S1– All Groups).
Tibias of Osx-Cre cKO mice were shorter at both 12 and 24
weeks than controls (p = 0.01 and p,0.0001, respectively,
Figure 3A–12 & 24 week males, Table SB in Tables S1– All
groups). Osx-Cre cKO mice at 12 weeks had smaller bones as
indicated by reduced cortical TV, cortical BV, cancellous TV, and
cancellous BV versus control (p = 0.006, 0.02, 0.02, 0.06,
respectively; Figure 3B, 3C and Table 1 – –12 & 24 week males,
Tables SB & SC in Tables S1– All groups). Interestingly, cortical









































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4. The forelimbs of mice were tested in axial compres-
sion. The ultimate force of the forelimb was significantly reduced in the
Osx-Cre cKO mice at 12 and 24 weeks.
doi:10.1371/journal.pone.0096862.g004
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(p = 0.005). Cancellous BV/TV was not affected, indicating
normal spatial density of trabeculae. By 24 weeks similar
differences for reduced cortical size remained in Osx-Cre cKO
mice versus controls (p = 0.0005 for TV, and p=0.017 for BV).
However, cancellous BV and TV were now similar to controls.
Cortical TMD of Osx-Cre cKO cortical bone was the same as
littermate Bmp2fl/fl controls at both ages (Figure 3D). In the VEC-
Cre mouse line the cKO mice had lower cortical bone BV/TV at
24 weeks (p = 0.016) and lower cancellous vBMD (p= 0.042), but
in contrast to the Osx-Cre cKO, all other outcomes including
those related to bone size were similar between VEC-Cre and
control groups (Tables SB & SC in Tables S1– All groups).
Osx-Cre cKO Bones have Altered Mechanical Properties
at Whole-bone and Material Levels
Whole forelimb strength was assessed by axial compression to
failure. The ultimate force (a measure of strength of the entire
structure) was significantly reduced in 12 and 24 week old Osx-
Cre cKO mice (40% and 34%, p= 0.013 and 0.050 respectively)
compared to littermate controls (Figure 4). There were no
differences in ultimate force for the VEC-Cre cKO mice
compared to WT.
Reduced strength of Osx-Cre forelimbs may be due to reduced
bone size or reduced bone material properties. To assess these two
factors, microCT and three-point bending were performed on
femora of Osx-Cre mice. Given that the tibial structure and
forelimb strength of VEC-Cre mice were not affected by BMP2
cKO, it was assumed unlikely there were any differences in the
material properties and no further tests on VEC-Cre mice were
performed.
MicroCT measurements of the femur midshaft corroborated
findings from the tibia, confirming a smaller bone in Osx-Cre
cKO versus WT (Figure 5, Table 2). In particular, Osx-Cre cKO
femora had a lower bone area, and moment of inertia (p = 0.004
and 0.006, respectively; Figure 5A). Force-displacement data from
three-point bending (Figure 5B) revealed that Osx-Cre cKO
femora had normal whole-bone stiffness (Figure 5C), but reduced
ultimate force (p = 0.004; Figure 5D) and dramatically decreased
post-yield displacement (p = 0.002; Figure 5E). In combination
these properties resulted in a significantly lower energy at ultimate
force and energy to fracture (p = 0.004 and 0.002, respectively,
Table 2), properties that reflect overall resistance to failure.
Despite the inferior whole-bone mechanical properties, femora
from Osx-Cre cKO mice actually had superior stiffness and
strength at the material level (i.e., after accounting for size
differences), as evidenced by the increased Young’s modulus
(p = 0.008; Figure 5F), and ultimate stress (p = 0.017 Figure 5G).
Thus, at the material level Osx-Cre cKO bones are stiff and
strong, but their reduced post-yield displacement indicates they are
brittle. These material properties, when combined with their
smaller size, result in a whole-bone that has normal stiffness but
inferior strength and reduced energy to failure.
Raman Spectroscopy
To determine if the differences in material properties of Osx-
Cre bones could be due to defects in the mineral or collagen aspect
of bone, we performed Raman Spectroscopy. First, a set of humeri
from 24-week old mice were analyzed as a pilot study. We then
analyzed the same 12-week old femora that had been used for
three-point bending (Table SD in Tables S1). Carbonated
hydroxylapatite was the only mineral present in both the WT
and the cKO specimens. The position of the deconvolved 960
Dcm21 band ranged from 960.5 to 961.3 wavenumbers for the 12-
week-old femora, which is normal for bone. This range indicate
some variability in the chemical components of the bone, for
instance by sodium incorporation as a result of carbonate
substitution [32,33] However, the mean band positions were not
statistically different between genotypes (p = 0. 92). Similarly, the
Figure 5. The femora of 12 and 24 week old Osx-Cre mice were tested in three-point bending. cKO mice had significantly reduced (A)
moment of inertia compared to WT controls. (B) Example force-displacement curves for WT and cKO mice demonstrate the differences in structural
properties (C) Stiffness was unchanged at either time point. However, (D) ultimate force and (E) post-yield displacement was decreased. (F) Young’s
modulus for cKO mice appears to be stiffer at both time points, but is only significant at 12 wks. Conversely, (G) ultimate stress is higher in cKO but
only significant at 24 weeks.
doi:10.1371/journal.pone.0096862.g005
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960 Dcm21 bandwidth varied, indicating a small difference in
atomic order, but was not statistically different by genotype
(p = 0.25). The mineral-to-matrix ratio, as represented by the ratio
of hydroxylapatite (area of the 960D cm21 band) to collagen (area
of the 1003 Dcm21 band), was lower in the cKO mice than in WT
for our pilot studies with 24-week-old humeri (p = 0.04), however
the ratio did not differ by genotype for the 12-week-old femora
(p = 0.37). No significant differences in features within the collagen
spectral region were observed between the WT and cKO mice. To
assess the degree of carbonate substitution, the area of the 1070 D
cm21 band (for Type-B carbonate substitution) was divided by the
area of the 960 Dcm21 band. The proportion of carbonate in the
mineral varied slightly within and between specimens, as is normal
in bone, but did not differ by genotype (p= 0. 84). In summary,
Raman spectroscopy revealed no obvious defects in the collagen or
mineral aspect of Osx-Cre cKO bones that would account for the
differences in mechanical and material properties.
Discussion
Our work shows that osteoblast-derived BMP2 is important to
post-natal skeletal growth, structure and strength whereas vascular
endothelial-derived BMP2 is not. Knockout of BMP2 using Osx-
Cre affected both the structure and strength of long bones.
Contrary to our hypothesis, the knockout of BMP2 from vascular
endothelial cells did not affect any whole-body and few long-bone
outcome measures for either sex, nor was the strength of the whole
forelimb altered.
Structurally, Osx-Cre cKO resulted in a smaller mouse with
slightly shorter limbs. This is a similar, but less severe, phenotype
than when BMP2 is knocked out of all osteo- and chondro-
progenitor cells using Prx1-Cre (Bmp2fl/fl;Prx1-Cre, a.k.a, Prx1-
Cre cKO) [9,10]. The shortness of the limbs we observed may be
due to the off-target knockout in non-bone cells such as
hypertrophic chondrocytes [31,34]. The Osx-Cre mouse is
reported to target several non-bone cell types [31]. However,
preliminary examination of growth plate morphology and cell
proliferation did not identify any obvious dissimilarities that could
account for the modest (10%) effect on tibial length. More
importantly, the smaller bone width and reduced cortical bone
volume, which would not be affected by hypertrophic chondro-
cytes, supports the hypothesis that BMP2 is a key factor in
periosteal osteoblasts. Furthermore, the similarity of the Osx-Cre
cKO phenotype to the reported phenotype in a Col 1-Cre cKO
[15] suggests that the effects are from bone cell deletion of BMP2.
Periosteal cells are responsible for radial bone expansion
throughout life [35] and are the main cellular contributors to
fracture repair [36]. The smaller total volume of Osx-Cre cKO
cortical bones indicate that if the osteoblasts and osteocytes are
unable to produce BMP2, the bone forming cells in the periosteal
layer fail to create enough bone to circumferentially expand
similar to controls. Recent work has suggested this maybe due to
indirect effects of periosteal cell BMP2 knockout. Progenitor cell
behavior and vasculature architecture is altered by BMP2
knockout in early stage osteoblasts [15]. More studies are
necessary to determine the relative importance of direct effects
on osteoblast function versus indirect effects from other sources
such as defective signals from the osteocytes or bone matrix that
does not contain BMP2.
An unexpected finding is that osteoblast-derived BMP2 is
involved in bone quality. The mechanical properties of Osx-Cre
cKO femora reflect a combination of their reduced size coupled
with size-independent properties derived from three-point bending
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Cre cKO is stiffer (higher Young’s modulus), marginally stronger
(higher ultimate stress at 24 weeks) and less ductile (decreased post-
yield displacement). This means that as a material the Osx-Cre
cKO bones behave just as well or better than their controls under
small deformations (i.e. normal loading conditions). However,
because they are less ductile, once plastic deformation occurs (i.e.
trauma) the bone material fails with less energy absorbed. While
not directly measured, the spontaneous fractures sustained by the
Prx1-Cre cKO mice suggest a similar but more severe material
defect [9,10]. In both the Osx- and Prx1-Cre cKO lines the size
discrepancy and material differences combine to create a weaker
limb. Our findings are consistent with a recent report in which
deletion of BMP2 using the 3.6Col1a1-Cre had a similar effect on
postyield bone toughness [15].
In an initial effort to identify the source of the material property
differences, we analyzed the femora with Raman spectroscopy, a
technique that can characterize the structure-composition and
degree of crystallinity of a material. Remarkably, there were no
obvious spectroscopic differences in the mineral or collagen
aspects of bone from cKO versus WT mice. Interestingly, the
finding of normal bone mineral from Raman analysis of intact
bones is in contradiction to the impaired in vitro mineralization in
differentiated mesenchymal stem cell cultures from 3.6Col1a1-
Cre; BMP2 cKO mice [15]. Nonetheless, given the strong link
between bone toughness and the organic phase of bone material
[37], further studies into the collagen alignment, cross linking, and
structure are warranted.
A caveat to this research was off-target effects in Osx-Cre cKO
teeth. All osteoblast knockout mice developed malocclusions that
worsened as they aged (Figure S1). An obvious concern is that
these mice could be malnourished, and the phenotype is due to
diet not genetics. However, several observations argue against this
possibility. First, there were no differences in percent fat in
12 week old Osx-Cre cKO mice and only modest differences at 24
weeks (Figure 2B). In mouse models of malnourishment percent fat
is significantly lower (,10%) by 12 weeks of age [38].
Furthermore, none of the heterozygous knockout mice (Bmp2fl/
+;Osx-Cre+) presented malocclusions yet many of their structure
and strength outcome measures fell between the knockouts and
controls (see Figure S2). This shows a possible dose effect of the
BMP2 knockout. Finally, a previous study by Feng et al.
documented that this knockout not only causes malocclusions,
but the mineralized tissue itself is altered; knockout teeth had
extensive pitting which suggests that the teeth are brittle [39],
similar to findings in our OSX-Cre cKO long bones. An
additional limitation as a result of the malocclusions was that we
had few Osx-Cre cKO mice at the later time point (24 weeks).
Once the severity of the malocclusions was documented the
experimental groups for Osx cKO were switched to a 12 week
timepoint.
Knockout of BMP2 from vascular endothelial cells changed few
aspects of skeletal growth up to 24 weeks of age. This was
unexpected given the many links between vasculature and bone
growth as well as between BMP2 and heart development, bone
healing, and arterial calcification. It is possible that BMP2 from
other cell types is capable of compensating for loss from vascular
cells during development and maturation. Alternatively, other
BMPs with overlapping functions (i.e. BMP4/7 [9]) may
compensate for loss of BMP2. Further discrimination between
these possibilities would require examination of BMP signaling at
the cell level, which we did not evaluate here. The effects of BMP2
loss from vascular endothelial cells may only be evident in stressed
situations such as a high fat diet or bone healing. It is known that
BMP2 is highly elevated in vascular endothelial cells at early
timepoints in healing via intramembranous bone formation (i.e.
stress fracture healing and distraction osteogenesis) [13,28].
Further studies are needed to test the requirement for vascular
BMP2 in these settings.
In conclusion, the knockout of osteoblast-derived BMP2 affects
the structure and strength of long bones while knockout of
vascular-endothelial cell BMP2 does not. The Bmp2fl/fl;Osx-Cre+
cKO mouse could serve as model to investigate the relationship
between bone mass density and fracture risk associated with Bmp2
polymorphisms in humans. The studies linking Bmp2 polymor-
phisms and osteoporosis are controversial and contradictory [40–
43]. This is due in part to the rarity of the genetic mutation, the
contribution of many different factors and genes to BMD, and the
relatively mild effects. Using this mouse we can investigate
mechanisms that may account for increased fracture risk and
then potentially translate these findings to the clinic.
Supporting Information
Figure S1 The teeth of Osx-Cre cKO mice were
abnormal. Example images demonstrate malocclusion in cKO
mice. The teeth ofK cKO mice were normal as were the teeth of
Osx-Cre WT mice and Cre control mice (no Bmp2 floxing).
(TIF)
Figure S2 Results for various structural and strength
measures from the Osx-CreK cKO bones were between
those of the Osx-Cre WT and Osx-Cre cKO.
(TIF)
Tables S1 Tables with DEXA (Table SA), micoCT
(Tables SB and SC), and Raman Spectroscopy (Table
SD) data for all experimental groups.
(XLSX)
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